These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37236204)

  • 1. JNK3 Overexpression in the Entorhinal Cortex Impacts on the Hippocampus and Induces Cognitive Deficiencies and Tau Misfolding.
    Ardanaz CG; Ezkurdia A; Bejarano A; Echarte B; Smerdou C; Martisova E; Martínez-Valbuena I; Luquin MR; Ramírez MJ; Solas M
    ACS Chem Neurosci; 2023 Jun; 14(11):2074-2088. PubMed ID: 37236204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human P301L-mutant tau expression in mouse entorhinal-hippocampal network causes tau aggregation and presynaptic pathology but no cognitive deficits.
    Harris JA; Koyama A; Maeda S; Ho K; Devidze N; Dubal DB; Yu GQ; Masliah E; Mucke L
    PLoS One; 2012; 7(9):e45881. PubMed ID: 23029293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of neurodegeneration in the entorhinal cortex that underlie its selective vulnerability during the pathogenesis of Alzheimer's disease.
    Olajide OJ; Suvanto ME; Chapman CA
    Biol Open; 2021 Jan; 10(1):. PubMed ID: 33495355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau Acetylation in Entorhinal Cortex Induces its Chronic Hippocampal Propagation and Cognitive Deficits in Mice.
    Wang X; Liu EJ; Liu Q; Li SH; Li T; Zhou QZ; Liu YC; Zhang H; Wang JZ
    J Alzheimers Dis; 2020; 77(1):241-255. PubMed ID: 32804150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease.
    Richter N; Bischof GN; Dronse J; Nellessen N; Neumaier B; Langen KJ; Drzezga A; Fink GR; van Eimeren T; Kukolja J; Onur OA
    J Alzheimers Dis; 2020; 78(4):1601-1614. PubMed ID: 33164934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propagation of tau pathology in a model of early Alzheimer's disease.
    de Calignon A; Polydoro M; Suárez-Calvet M; William C; Adamowicz DH; Kopeikina KJ; Pitstick R; Sahara N; Ashe KH; Carlson GA; Spires-Jones TL; Hyman BT
    Neuron; 2012 Feb; 73(4):685-97. PubMed ID: 22365544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.
    Guzman VA; Carmichael OT; Schwarz C; Tosto G; Zimmerman ME; Brickman AM;
    Alzheimers Dement; 2013 Oct; 9(5 Suppl):S124-31. PubMed ID: 23375566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network activity changes in the pathophysiology of Alzheimer's disease: the role of aging and early entorhinal cortex dysfunction.
    Setti SE; Reed MN
    Metab Brain Dis; 2022 Feb; 37(2):289-298. PubMed ID: 34591222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
    Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
    Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional differences in Alzheimer's disease pathology confound behavioural rescue after amyloid-β attenuation.
    Morrone CD; Bazzigaluppi P; Beckett TL; Hill ME; Koletar MM; Stefanovic B; McLaurin J
    Brain; 2020 Jan; 143(1):359-373. PubMed ID: 31782760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemogenetic attenuation of neuronal activity in the entorhinal cortex reduces Aβ and tau pathology in the hippocampus.
    Rodriguez GA; Barrett GM; Duff KE; Hussaini SA
    PLoS Biol; 2020 Aug; 18(8):e3000851. PubMed ID: 32822389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
    Wang D; Fei Z; Luo S; Wang H
    Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory performance is related to amyloid and tau pathology in the hippocampus.
    Reitz C; Honig L; Vonsattel JP; Tang MX; Mayeux R
    J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):715-21. PubMed ID: 19258354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
    King-Robson J; Wilson H; Politis M;
    J Alzheimers Dis; 2021; 82(2):541-560. PubMed ID: 34057079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau-tubulin kinase 1 and amyloid-β peptide induce phosphorylation of collapsin response mediator protein-2 and enhance neurite degeneration in Alzheimer disease mouse models.
    Ikezu S; Ingraham Dixie KL; Koro L; Watanabe T; Kaibuchi K; Ikezu T
    Acta Neuropathol Commun; 2020 Feb; 8(1):12. PubMed ID: 32019603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy.
    Gourmaud S; Shou H; Irwin DJ; Sansalone K; Jacobs LM; Lucas TH; Marsh ED; Davis KA; Jensen FE; Talos DM
    Brain; 2020 Jan; 143(1):191-209. PubMed ID: 31834353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of entorhinal cortical tau deposition and hippocampal synaptic density in older individuals with normal cognition and early Alzheimer's disease.
    Mecca AP; Chen MK; O'Dell RS; Naganawa M; Toyonaga T; Godek TA; Harris JE; Bartlett HH; Zhao W; Banks ER; Ni GS; Rogers K; Gallezot JD; Ropchan J; Emery PR; Nabulsi NB; Vander Wyk BC; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
    Neurobiol Aging; 2022 Mar; 111():44-53. PubMed ID: 34963063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study.
    Lace G; Savva GM; Forster G; de Silva R; Brayne C; Matthews FE; Barclay JJ; Dakin L; Ince PG; Wharton SB;
    Brain; 2009 May; 132(Pt 5):1324-34. PubMed ID: 19321462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JNK Activation in Alzheimer's Disease Is Driven by Amyloid β and Is Associated with Tau Pathology.
    Solas M; Vela S; Smerdou C; Martisova E; Martínez-Valbuena I; Luquin MR; Ramírez MJ
    ACS Chem Neurosci; 2023 Mar; 14(8):1524-34. PubMed ID: 36976903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral inflammation promotes brain tau transmission via disrupting blood-brain barrier.
    Liu Y; Zhang S; Li X; Liu E; Wang X; Zhou Q; Ye J; Wang JZ
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.